Angiotensin II Type 1 Receptor Blockers Inhibit KAT II Activity in the Brain—Its Possible Clinical ApplicationsIzabela Zakrocka, Waldemar A. Turski, Tomasz Kocki et al.|Neurotoxicity Research|2017Cited by 36
Preclinical effects of cannabidiol in an experimental model of migraineChiara Sturaro, Andrea Cippitelli, Lawrence Toll et al.|Pain|2023Cited by 17
Influence of Cyclooxygenase-2 Inhibitors on Kynurenic Acid Production in Rat Brain in VitroIzabela Zakrocka, Waldemar A. Turski, Artur Wnorowski et al.|Neurotoxicity Research|2018Cited by 12
Angiotensin II type 1 receptor blockers decrease kynurenic acid production in rat kidney in vitroIzabela Zakrocka, Waldemar A. Turski, Katarzyna M. Targowska‐Duda et al.|Naunyn-Schmiedeberg s Archives of Pharmacology|2018Cited by 10